(19)
(11) EP 1 274 859 A1

(12)

(43) Date of publication:
15.01.2003 Bulletin 2003/03

(21) Application number: 00976987.8

(22) Date of filing: 06.11.2000
(51) International Patent Classification (IPC)7C12Q 1/48, C12N 9/12, C12N 15/54
(86) International application number:
PCT/US0030/542
(87) International publication number:
WO 0103/2918 (10.05.2001 Gazette 2001/19)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 05.11.1999 US 163901 P
03.11.2000 US 706426

(71) Applicants:
  • SmithKline Beecham Corporation
    Philadelphia, PA 19130 (US)
  • SmithKline Beecham plc
    Brentford,Middlesex TW8 9GS (GB)

(72) Inventors:
  • KASSIS, Shouki
    Audubon, PA 19403 (US)
  • ANNAN, Roland, S.
    West Chester, PA 19382 (US)
  • LEE, John, C.
    Indianapolis, IN 46260 (US)

(74) Representative: Stott, Michael John 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) SPECIFIC PEPTIDE SUBSTRATE FOR HUMAN YAK1, YAK3A, AND YAK3B AND YEAST YAK1 PROTEIN KINASES